Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Shanghai, Jun 23, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine ("the Company", stock...
